Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Affamed, Arch Biopartners, Ascletis, Beigene, Biontech, Cstone, Jixing, Lupin, Moderna, Zai Lab.